Sarah is a Partner and Head of our Life Sciences and Chemistry group. She specialises in the field of biotechnology, and has significant expertise and experience in the areas of antibody and TCR technology, synthetic biology, next-generation DNA sequencing technologies, proteomics and diagnostics.
She has a burgeoning practice in technologies where the life sciences intersects with other fields, including bioinformatics and digital health. For such technologies, an interdisciplinary approach is often required, for example when machine learning and AI are used in the life sciences field. Sarah enjoys working together with her colleagues across the firm as part of a truly interdisciplinary team to provide a bespoke experience to clients in these sectors.
With over 20 years’ experience, Sarah is skilled at handling all stages of the patenting process, from the initial stages of invention capture and drafting patent applications through international prosecution to EPO oppositions and appeals. Although she has a wide client base, she particularly enjoys using her formidable strategic and commercial skills to help clients achieve their business aims, whether those are raising further funds, initial public offering or launching a product. She is renowned for her brilliant client care, with IAM Patent, 2024 noting “She blends a commercially pragmatic approach with a personalised service and tailored solutions, to ensure her patrons come out on top.”
When not working with clients to develop and deliver their IP strategies, Sarah is responsible for the delivery of the Life Sciences & Chemistry group’s strategic plan. She also speaks regularly on aspects of European and UK patent practice and current IP issues in the life sciences.